PIK3CA and colorectal cancer: The glycyrrhizin metabolite, 18-β-glycyrrhetinic acid, shows anticancer effects in colorectal cancer by suppressing PI3K and STAT3 signaling, leading to reduced cell proliferation, migration, and invasion in LoVo, SW480, and SW620 cells [133].